Issue: April 10, 2016
April 10, 2016
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Head and Neck Cancer Drugs in the Pipeline
Issue: April 10, 2016
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
HemOnc Today presents this guide to drugs in phase 2 or phase 3 development for head and neck cancer. Clinicians can use this chart as a quick reference to learn about the status of those drugs that may be clinically significant to their practice.